RNA
Price
$30.91
Change
+$0.23 (+0.75%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
3.72B
18 days until earnings call
VINC
Price
$0.07
Change
-$0.03 (-30.00%)
Updated
Apr 23 closing price
Capitalization
523.43K
14 days until earnings call
Ad is loading...

RNA vs VINC

Header iconRNA vs VINC Comparison
Open Charts RNA vs VINCBanner chart's image
Avidity Biosciences
Price$30.91
Change+$0.23 (+0.75%)
Volume$29.1K
Capitalization3.72B
Vincerx Pharma
Price$0.07
Change-$0.03 (-30.00%)
Volume$1.1M
Capitalization523.43K
RNA vs VINC Comparison Chart
Loading...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNA vs. VINC commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNA is a Buy and VINC is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (RNA: $30.68 vs. VINC: $0.07)
Brand notoriety: RNA and VINC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNA: 78% vs. VINC: 86%
Market capitalization -- RNA: $3.72B vs. VINC: $523.43K
RNA [@Biotechnology] is valued at $3.72B. VINC’s [@Biotechnology] market capitalization is $523.43K. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNA’s FA Score shows that 0 FA rating(s) are green whileVINC’s FA Score has 1 green FA rating(s).

  • RNA’s FA Score: 0 green, 5 red.
  • VINC’s FA Score: 1 green, 4 red.
According to our system of comparison, RNA is a better buy in the long-term than VINC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNA’s TA Score shows that 4 TA indicator(s) are bullish while VINC’s TA Score has 4 bullish TA indicator(s).

  • RNA’s TA Score: 4 bullish, 5 bearish.
  • VINC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VINC is a better buy in the short-term than RNA.

Price Growth

RNA (@Biotechnology) experienced а +19.10% price change this week, while VINC (@Biotechnology) price change was -74.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

RNA is expected to report earnings on Aug 12, 2025.

VINC is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($3.72B) has a higher market cap than VINC($523K). RNA YTD gains are higher at: 5.502 vs. VINC (-98.649). VINC has higher annual earnings (EBITDA): -27.1M vs. RNA (-376.16M). RNA has more cash in the bank: 1.5B vs. VINC (80.9M). VINC has less debt than RNA: VINC (1.64M) vs RNA (6.8M). RNA has higher revenues than VINC: RNA (10.9M) vs VINC (0).
RNAVINCRNA / VINC
Capitalization3.72B523K710,899%
EBITDA-376.16M-27.1M1,388%
Gain YTD5.502-98.649-6%
P/E RatioN/AN/A-
Revenue10.9M0-
Total Cash1.5B80.9M1,855%
Total Debt6.8M1.64M415%
TECHNICAL ANALYSIS
Technical Analysis
RNAVINC
RSI
ODDS (%)
N/A
Bullish Trend 10 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 10 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 10 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 10 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 10 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 10 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 23 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 10 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 10 days ago
89%
View a ticker or compare two or three
Ad is loading...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VINC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICHR19.501.88
+10.67%
Ichor Holdings
TLS2.680.10
+3.88%
Telos Corp
IRD0.750.02
+2.15%
Opus Genetics Inc
DOOO33.480.60
+1.82%
BRP
LULU265.854.14
+1.58%
lululemon athletica

VINC and

Correlation & Price change

A.I.dvisor indicates that over the last year, VINC has been loosely correlated with APVO. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VINC jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VINC
1D Price
Change %
VINC100%
-29.00%
APVO - VINC
33%
Loosely correlated
+4.05%
RNA - VINC
31%
Poorly correlated
+4.18%
VNDA - VINC
30%
Poorly correlated
-1.81%
IOVA - VINC
30%
Poorly correlated
-0.62%
CRIS - VINC
29%
Poorly correlated
+4.90%
More